Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J
Summary Numerous medical treatments are available to treat endometriosis
UA inhibits osteoclastogenesis induced by receptor activator of nuclear factor kappa-B ligand in a concentration-dependent manner, effectively mitigating bone loss (35)
The lyophilized powder format supports peptide stability during storage before reconstitution according to established laboratory procedures